# A PILOT STUDY OF DIFFUSION WEIGHTED MRI TO ASSESS ESOPHAGEAL TUMOR RESONSE TO NEOADJUVANT CHEMORADIATION

> **NCT03151642** · — · COMPLETED · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 11 (actual)

## Conditions studied

- Esophageal Cancer

## Interventions

- **RADIATION:** Chemotherapy
- **RADIATION:** Radiation Therapy
- **PROCEDURE:** Surgery
- **DEVICE:** MRI Imaging
- **OTHER:** Blood Draws

## Key facts

- **NCT ID:** NCT03151642
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-05
- **Primary completion:** 2019-08-23
- **Final completion:** 2021-04-23
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2021-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03151642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03151642, "A PILOT STUDY OF DIFFUSION WEIGHTED MRI TO ASSESS ESOPHAGEAL TUMOR RESONSE TO NEOADJUVANT CHEMORADIATION". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03151642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*